FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit!

Cedars-Sinai Medical Center

Innovative Therapy Zolbetuximab In Combination With Chemotherapy Significantly Improves Survival Of Gastric Cancer Patients!

For Fatal Rhabdomyosarcoma, New Atr Inhibitors May Hold Therapeutic Promise

Important Target For Novel NK Immune Checkpoint Inhibitor Identified!

Biyze For The Treatment Of Chronic Lymphocytic Leukaemia And Marginal Zone Lymphoma